StockData
Ceribell, Inc. logo

Ceribell, Inc. (CBLL) stock

CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$25.63−0.34 (-1.31%)

Close on Nov 18, 2026Market cap $983.63MP/E –Yield –

Ceribell free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Ceribell's free cash flow for the twelve months ending Jun 30, 2026 was -$54.72M. For fiscal 2025 it was -$41.58M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$41.58M–
FY2024Dec 31, 2024-$36.38M–
FY2023Dec 31, 2023-$30.14M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$12.88M–
Q1 FY2026Mar 31, 2026-$19.42M–
Q4 FY2025Dec 31, 2025-$10.95M–
Q3 FY2025Sep 30, 2025-$11.47M–
Q2 FY2025Jun 30, 2025-$7.60M–
Q1 FY2025Mar 31, 2025-$11.55M–
Q4 FY2024Dec 31, 2024-$10.33M–
Q3 FY2024Sep 30, 2024-$9.11M–
Q2 FY2024Jun 30, 2024-$7.30M–
Q1 FY2024Mar 31, 2024-$9.65M–
Q4 FY2023Dec 31, 2023-$7.15M–

More Ceribell figures

See a number that looks wrong?